Last reviewed · How we verify
NCT00075101
Sleep, Fatigue, and Dexamethosone in Childhood Cancer
Phase 3 trial testing Dexamethosone in Leukemia in 134 participants. Completed in 1 September 2006.
1 September 2006
Quick facts
| Lead sponsor | National Institute of Nursing Research (NINR) |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 134 |
| Start date | 1 September 2000 |
| Primary completion | 1 September 2006 |
| Estimated completion | 1 September 2006 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dexamethosone — full drug profile →
Conditions studied
- Leukemia — all drugs for Leukemia →
Sponsor
National Institute of Nursing Research (NINR)
Who can join
Adults 5 to 21, any sex, with Leukemia. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Fatigue and sleep quality changes
Time frame: 10 days
Sponsor's own description
The purpose of this study is to determine the relationship between dexamethosone (steroid) and children's sleep and fatigue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00075101
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Leukemia
Currently open trials in the same condition.
- NCT07405424 — Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia · NA · recruiting
- NCT07249346 — Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease ( · Phase 2 · recruiting
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT06856226 — Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing · recruiting
- NCT07148180 — A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: · Phase 1, PHASE2 · recruiting
Other National Institute of Nursing Research (NINR) trials
Trials by the same sponsor.
- NCT04141696 — A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue · Phase 1, PHASE2 · completed
- NCT04883359 — Immersive VR Environments to Induce and Evaluate Cognitive Fatigability · terminated
- NCT03998358 — Characterization of Fatigue in Military Personnel With Traumatic Brain Injuries · withdrawn
- NCT03394040 — Point-of-Use Pathogen Identification Tool for Diarrhea · terminated
- NCT02931474 — Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and · Phase 2 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00075101 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Nursing Research (NINR)
- Last refreshed: 14 August 2008
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00075101.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing